Caribou Biosciences, Inc. financial data

Symbol
CRBU on Nasdaq
Location
Berkeley, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 641% % -24%
Debt-to-equity 34% % 60%
Return On Equity -92% % -82%
Return On Assets -68% % -65%
Operating Margin -1329% % 20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96,637,202 shares 3.9%
Common Stock, Shares, Outstanding 95,143,690 shares 3%
Entity Public Float $112,500,000 USD -20%
Common Stock, Value, Issued $9,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 93,389,283 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 93,389,283 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $11,159,000 USD 12%
Research and Development Expense $109,439,000 USD -16%
General and Administrative Expense $37,914,000 USD -18%
Operating Income (Loss) $148,344,000 USD 11%
Nonoperating Income (Expense) $331,000 USD -102%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $148,125,000 USD 0.66%
Earnings Per Share, Basic -1.59 USD/shares 3.6%
Earnings Per Share, Diluted -1.59 USD/shares 3.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $12,360,000 USD -24%
Cash, Cash Equivalents, and Short-term Investments $142,800,000 USD -43%
Accounts Receivable, after Allowance for Credit Loss, Current $69,000 USD -74%
Assets, Current $145,232,000 USD -34%
Property, Plant and Equipment, Net $6,760,000 USD -65%
Operating Lease, Right-of-Use Asset $17,670,000 USD -12%
Other Assets, Noncurrent $2,200,000 USD -60%
Assets $175,367,000 USD -44%
Accounts Payable, Current $5,783,000 USD 134%
Employee-related Liabilities, Current $6,109,000 USD -49%
Accrued Liabilities, Current $16,535,000 USD -30%
Contract with Customer, Liability, Current $1,895,000 USD -39%
Liabilities, Current $25,414,000 USD -17%
Contract with Customer, Liability, Noncurrent $1,752,000 USD -47%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $26,026,000 USD 3.9%
Liabilities $53,192,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $103,000 USD -60%
Retained Earnings (Accumulated Deficit) $596,515,000 USD -33%
Stockholders' Equity Attributable to Parent $122,175,000 USD -52%
Liabilities and Equity $175,367,000 USD -44%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $36,725,000 USD 1.3%
Net Cash Provided by (Used in) Financing Activities $468,000 USD -96%
Net Cash Provided by (Used in) Investing Activities $49,381,000 USD 115%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 95,143,690 shares 3%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13,124,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12,406,000 USD -24%
Deferred Tax Assets, Valuation Allowance $186,924,000 USD 27%
Deferred Tax Assets, Gross $191,189,000 USD 23%
Operating Lease, Liability $27,227,000 USD 2.8%
Payments to Acquire Property, Plant, and Equipment $1,042,000 USD -28%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $148,277,000 USD 0.4%
Lessee, Operating Lease, Liability, to be Paid $43,815,000 USD 15%
Property, Plant and Equipment, Gross $20,287,000 USD -37%
Operating Lease, Liability, Current $1,201,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,014,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,842,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.138 pure 22%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16,588,000 USD 43%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,513,000 USD 10%
Unrecognized Tax Benefits $10,034,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,728,000 USD 9.9%
Operating Lease, Payments $711,000 USD -35%
Additional Paid in Capital $718,578,000 USD 2.5%
Depreciation, Depletion and Amortization $1,165,000 USD 64%
Deferred Tax Assets, Net of Valuation Allowance $4,265,000 USD -43%
Share-based Payment Arrangement, Expense $12,680,000 USD -24%